Company Analysis

Neuropace, Inc. (NPCE)

Nasdaq: NPCE · Surgical & Medical Instruments & Apparatus · Mountain View, CA · filing with the SEC since 2011
Grade5.8
◀ Past 6.5● Present 5.2▶ Future 5.7
1 est.

Who runs Neuropace, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Becker Joel
CHIEF EXECUTIVE OFFICER. First filing Jul 2023, latest Sep 4, 2026, 0 filings in all.
Officers reporting now
3
of 10 people with a filing in the last fifteen months
Directors reporting now
7
15 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Morrell MarthaCHIEF MEDICAL OFFICERApr 2021Sep 25, 20261 · $400,000
Williams Patrick F.Chief Financial OfficerJun 2025Sep 21, 2026none
Becker JoelCHIEF EXECUTIVE OFFICERJul 2023Sep 4, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Fischer Frank MdirectorApr 2021Jun 22, 2026none
Geiger UridirectorJan 2023Jun 22, 2026none
Kumar RakhidirectorApr 2021Jun 22, 2026none
Andrade LisadirectorNov 2021Jun 5, 2026none
Huennekens R ScottdirectorJan 2025Jun 5, 2026none
Ryan ReneedirectorApr 2021Jun 5, 2026none
Lacob JosephdirectorApr 2021Mar 24, 2026none
Earlier names on the record9, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton NPCE · research, not advice